Compound Evidence File
#EC-2026-0422
NA Semax Amidate
Filed under Peptides. The bureau holds 148 laboratory returns for this compound from 62 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
62 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Mar 2026 | 4 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 6 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 7 Dec 2025 | 7 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 7 Jul 2026 | 10 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 19 Jan 2026 | 19 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 16 May 2026 | 9 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Feb 2026 | 5 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Apr 2026 | 4 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Jun 2026 | 11 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 18 Apr 2026 | 28 Jun 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Jan 2026 | 3 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 15 Dec 2025 | 6 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Jan 2026 | 26 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Dec 2025 | 16 Aug 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 23 Dec 2025 | 16 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 14 Dec 2025 | 11 Mar 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 9.9 | 5 Dec 2025 | 4 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Apr 2026 | 9 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 25 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 9.9 | 9 Nov 2025 | 27 Nov 2025 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Jan 2026 | 1 Mar 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 9.4 | 9.4 | 9.4 | 11 Jun 2025 | 11 Jun 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 9.3 | 9.3 | 9.3 | 21 May 2025 | 21 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.2 | 8.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 9.1 | 9.1 | 9.1 | 14 Jan 2025 | 14 Jan 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 1 | 9.0 | 9.0 | 9.0 | 2 Jul 2025 | 2 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 8.9 | 7.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 8.6 | 8.1 | 9.0 | 2 Jul 2025 | 19 Jan 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.6 | 8.6 | 8.6 | 28 Mar 2025 | 28 Mar 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 8.4 | 8.4 | 8.4 | 25 Apr 2025 | 25 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.3 | 7.7 | 8.8 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.1 | 6.5 | 8.8 | 24 May 2026 | 24 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 | 21 May 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 | 3 Jun 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 7.8 | 6.9 | 8.8 | 24 May 2026 | 24 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 | 27 Feb 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 7.7 | 7.7 | 7.7 | 17 Dec 2024 | 17 Dec 2024 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 7.5 | 7.4 | 7.5 | 24 Apr 2025 | 21 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 11 | 7.1 | 4.5 | 9.5 | 3 Jul 2025 | 26 Jan 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 7.1 | 7.1 | 7.1 | 6 May 2025 | 6 May 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 7.1 | 7.1 | 7.1 | 21 May 2025 | 21 May 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 | 7 May 2025 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 | 25 Apr 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 6.4 | 4.3 | 8.5 | 13 Jun 2025 | 21 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 | 27 Feb 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 6.4 | 6.4 | 6.4 | 13 Feb 2025 | 13 Feb 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 6.3 | 6.3 | 6.3 | 2 Apr 2025 | 2 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 | 3 Jul 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 6.2 | 6.2 | 6.2 | 16 Mar 2025 | 16 Mar 2025 |
| OupeptideCASE #VI-2026-0435 | X | 9 | 6.1 | 4.0 | 7.5 | 27 Feb 2025 | 19 Jan 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 6.1 | 6.1 | 6.1 | 24 Apr 2025 | 24 Apr 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 | 11 Jun 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 2 | 5.7 | 3.4 | 7.9 | 6 May 2025 | 17 May 2026 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 5.7 | 5.7 | 5.7 | 14 Jan 2025 | 14 Jan 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 2 | 5.2 | 3.4 | 7.1 | 25 Apr 2025 | 19 Jan 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 4.9 | 4.9 | 4.9 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 2.9 | 2.9 | 2.9 | 27 Feb 2025 | 27 Feb 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for NA Semax Amidate alone.